G Bussolati Selected Research

G Bussolati Research Topics

Disease

16	Neoplasms (Cancer) 12/2007 - 03/2000
7	Carcinoma (Carcinomatosis) 04/2004 - 05/2000
6	Breast Neoplasms (Breast Cancer) 01/2008 - 01/2001
2	Thyroid Neoplasms (Thyroid Cancer) 01/2006 - 05/2001
2	Adenocarcinoma 09/2001 - 03/2000
2	Adenoma (Adenomas) 08/2001 - 09/2000
2	Endometrial Neoplasms (Endometrial Cancer) 06/2001 - 03/2000
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013
1	Dehydration (Water Stress) 01/2012
1	Papillary Thyroid Cancer 01/2010
1	Ductal Carcinoma 10/2003
1	Neoplasm Metastasis (Metastasis) 03/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2001
1	Malignant Mesothelioma 09/2001
1	Neuroendocrine Carcinoma 09/2001
1	Glioblastoma (Glioblastoma Multiforme) 06/2001
1	Neuroblastoma 06/2001
1	Thyroid Nodule (Nodule, Thyroid) 05/2001
1	Choriocarcinoma 03/2001
1	Hemangiosarcoma (Angiosarcoma) 12/2000
1	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2000
1	Hyperplasia 09/2000
1	Secondary Hyperparathyroidism 09/2000
1	Osteosarcoma (Osteogenic Sarcoma) 07/2000
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2000
1	Carcinoid Tumor (Carcinoid) 03/2000
1	Small Cell Carcinoma 03/2000
1	Asphyxia (Suffocation) 01/2000
1	HIV Infections (HIV Infection) 01/2000
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

7	Oxytocin Receptors (Oxytocin Receptor)IBA 04/2004 - 03/2000
5	Oxytocin (Pitocin)FDA LinkGeneric 04/2004 - 07/2000
4	Biological ProductsIBA 04/2004 - 03/2000
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2002 - 03/2000
4	Messenger RNA (mRNA)IBA 01/2001 - 03/2000
3	Proteins (Proteins, Gene)FDA Link 10/2003 - 09/2000
3	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2002 - 03/2000
2	ParaffinIBA 01/2012 - 03/2000
2	Trastuzumab (Herceptin)FDA Link 12/2007 - 04/2005
2	Galectin 3 (LGALS3)IBA 01/2006 - 05/2001
2	Indicators and Reagents (Reagents)IBA 04/2005 - 06/2001
2	Octreotide (Sandostatin)FDA LinkGeneric 12/2001 - 03/2000
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2001 - 03/2000
2	Androgen Receptors (Androgen Receptor)IBA 08/2001 - 05/2001
1	Lamin B ReceptorIBA 01/2010
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2008
1	Nucleic AcidsIBA 12/2001
1	pentetreotide (OctreoScan)FDA Link 12/2001
1	AsbestosIBA 09/2001
1	AntigensIBA 09/2001
1	Keratins (Keratin)IBA 09/2001
1	CaspasesIBA 08/2001
1	Differentiation AntigensIBA 08/2001
1	Estrogen ReceptorsIBA 08/2001
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2001
1	AcidsIBA 06/2001
1	Chelating AgentsIBA 06/2001
1	LigandsIBA 06/2001
1	Vasotocin (Argiprestocin)IBA 06/2001
1	Tyrosine (L-Tyrosine)FDA Link 03/2001
1	Peptides (Polypeptides)IBA 03/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2001
1	Complement System Proteins (Complement)IBA 01/2001
1	Hormones (Hormone)IBA 01/2001
1	ChromograninsIBA 01/2001
1	SynaptophysinIBA 01/2001
1	Biogenic Amines (Biogenic Amine)IBA 01/2001
1	AndrogensIBA 01/2001
1	Thyroglobulin FDA Link 12/2000
1	Oxygen (Dioxygen)IBA 10/2000
1	SilverIBA 09/2000
1	Fibrinolysin FDA Link 07/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2000
1	OsteocalcinIBA 07/2000
1	Monoclonal AntibodiesIBA 03/2000
1	somatostatin receptor 2IBA 03/2000
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2000
1	Surface-Active Agents (Surfactants)IBA 01/2000

Therapy/Procedure

5	Therapeutics 01/2013 - 01/2000
2	Cesarean Section (Caesarean Section) 01/2000 - 01/2000
1	Drug Therapy (Chemotherapy) 04/2005
1	Adjuvant Chemotherapy 03/2003